166 related articles for article (PubMed ID: 6663185)
1. [HbAI as an indicator of blood glucose regulation in diabetic patients].
Oimomi M; Ishikawa K; Kawasaki T; Kubota S; Takagi K; Tanke G; Yoshimura Y; Baba S
Nihon Naika Gakkai Zasshi; 1983 Sep; 72(9):1159-62. PubMed ID: 6663185
[No Abstract] [Full Text] [Related]
2. Translating hemoglobin A1c into average blood glucose: implications for clinical chemistry.
Sacks DB
Clin Chem; 2008 Nov; 54(11):1756-8. PubMed ID: 18931015
[No Abstract] [Full Text] [Related]
3. Implications of point-of-care testing for hemoglobin A1c.
Porter KH; Myers GL
Diabetes Technol Ther; 2000; 2(4):527-8. PubMed ID: 11469614
[No Abstract] [Full Text] [Related]
4. [Biological surveillance of diabetes mellitus: point of view of the diabetologist].
Grimaldi A
Ann Biol Clin (Paris); 1999; 57(4):458-62. PubMed ID: 10432369
[No Abstract] [Full Text] [Related]
5. Problems in the assessment of glycaemic control in diabetes mellitus.
Kilpatrick ES
Diabet Med; 1997 Oct; 14(10):819-31. PubMed ID: 9371473
[TBL] [Abstract][Full Text] [Related]
6. Glycosylated hemoglobin and its temporal relationship to plasma glucose in non-insulin dependent (type 2) diabetes mellitus.
Borsey DQ; Fraser DM; Gray RS; Elton RA; Smith AF; Clarke BF
Metabolism; 1982 Apr; 31(4):362-5. PubMed ID: 7078419
[TBL] [Abstract][Full Text] [Related]
7. Fructosamine, hemoglobin A1c, and measures of diabetic control.
Hom F
Diabetes Technol Ther; 1999; 1(4):443-5. PubMed ID: 11474830
[No Abstract] [Full Text] [Related]
8. [Is glycated hemoglobin always a reliable marker of long term metabolic control in diabetic patients?].
Leutenegger M
Diabete Metab; 1991; 17(4):424-7. PubMed ID: 1916002
[No Abstract] [Full Text] [Related]
9. [Glycated hemoglobin level is a tool for monitoring the efficiency of treatment in patients with diabetes mellitus in the Moscow Region].
Tishenina RS; Dreval' AV; Misnikova IV; Kovaleva IuA; Fokina SS
Klin Lab Diagn; 2008 May; (5):17-9. PubMed ID: 18592642
[No Abstract] [Full Text] [Related]
10. Glycosylated haemoglobin. Part II: Labile glycosylated hemoglobin--is it clinically important?
Kennedy L
Diabet Med; 1985 Mar; 2(2):86-7. PubMed ID: 2952407
[No Abstract] [Full Text] [Related]
11. Glycosal. Commentary.
Peterson CM
Diabetes Technol Ther; 1999; 1(4):433-4. PubMed ID: 11474828
[No Abstract] [Full Text] [Related]
12. Quality specifications for clinical chemical analyses used to monitor patients with diabetes mellitus.
Berne C
Ups J Med Sci; 1990; 95(3):191-6. PubMed ID: 2100394
[No Abstract] [Full Text] [Related]
13. FDA clears home glycated hemoglobin test for diabetics.
Walczak IM
Diabetes Technol Ther; 2003; 5(1):124. PubMed ID: 12733538
[No Abstract] [Full Text] [Related]
14. Managing diabetes in hospitalized patients with chronic kidney disease.
Iyer SN; Tanenberg RJ
Cleve Clin J Med; 2016 Apr; 83(4):301-10. PubMed ID: 27055204
[TBL] [Abstract][Full Text] [Related]
15. The clinical information value of the glycosylated hemoglobin assay.
Nathan DM; Singer DE; Hurxthal K; Goodson JD
N Engl J Med; 1984 Feb; 310(6):341-6. PubMed ID: 6690962
[TBL] [Abstract][Full Text] [Related]
16. Glycohemoglobin testing in patients with diabetes: it may be underutilized now, but that is certain to change.
Goldstein DE
Diabetes Technol Ther; 1999; 1(4):421-3. PubMed ID: 11474826
[No Abstract] [Full Text] [Related]
17. Clinical validity of a self-test fructosamine in outpatient diabetic management.
Cefalu WT; Wang ZQ; Redmon E; Bell-Farrow AD; McBride D; King T
Diabetes Technol Ther; 1999; 1(4):435-41. PubMed ID: 11474829
[TBL] [Abstract][Full Text] [Related]
18. Assessing blood glucose control in diabetes mellitus. Use precise analytical methods.
Standing S; Taylor R
BMJ; 1995 Mar; 310(6981):740; author reply 741. PubMed ID: 7711561
[No Abstract] [Full Text] [Related]
19. An alternative approach to the diagnosis of diabetes with a review of the literature.
Davidson MB; Peters AL; Schriger DL
Diabetes Care; 1995 Jul; 18(7):1065-71. PubMed ID: 7555543
[No Abstract] [Full Text] [Related]
20. Case Study: using a continuous glucose monitoring system in a patient with diabetes and beta-thalassemia hemoglobinopathy.
Al-Futaisi A; Wali Y; El-Beshlawi I; Al-Riyami S; Almahrezi A
Pediatr Hematol Oncol; 2009; 26(7):515-9. PubMed ID: 19863207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
